Why Was Alpha Teknova Stock Up on Aug 6, 2026?

Alpha Teknova shares are trading higher again in pre-market trading today, continuing to build on the reaction to yesterday's second-quarter 2026 results. The small life-sciences reagent manufacturer reported record revenue of $12.19 million, up 18% year over year and above the $10.97 million analysts had estimated. The adjusted loss narrowed to $0.06 per share from an expected $0.08 loss, and gross margin expanded 1.4 percentage points to 40.1%.

The company also raised its full-year 2026 revenue guidance to $45 million-$47 million from a prior $42 million-$44 million range, citing increased confidence in demand across its Lab Essentials and Clinical Solutions product lines. A quarter that combines a revenue record, a narrower loss, expanding margin, and a guidance raise — with no offsetting weak spot — is a genuinely clean set of results, which is likely why today's follow-through has extended rather than reversed yesterday's move. For the full breakdown, see our dated report on the results.